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Abstract New neurotechnologies for modulating brain
functions are becoming increasingly powerful and appli-
cable to diverse diseases, but raise new questions for cli-
nicians, ethicists, policy makers, and laymen. This issue of
Brain Topography gathers several papers exploring the
clinical and ethical implications of several invasive and
noninvasive neuromodulation approaches. The opportuni-
ties and challenges associated with the emergence of
neuro-engineering solutions to brain research and brain
repair require a close dialogue between multiple disci-
plines, as well as open discussion with the general public.
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In the past two decades, tremendous progress has been
made in brain sciences. We are just beginning to envision
their enormous impact for many clinical conditions as well
as their consequences for more global societal issues. It is
likely that under the influence of new neuroscience tech-
niques and knowledge, the clinical practice of neurology
and psychiatry is about to witness major changes in diag-
nosis and treatment which will not only revolutionize
medicine, but possibly also change our vision of human
nature.
Modern brain research is now capable of elucidating the
detailed neuronal circuitry involved in various behaviors
and cognitive functions. It becomes possible to link complex
mental states or phenomena to their underlying biological
processes at various levels of analysis. This understanding is
growing at a rapid pace and ranges from large-scale cortico-
subcortical networks through to synaptic, cellular, and
subcellular systems pertaining to molecular, genetic, and
even epigenetic mechanisms. Moreover, the realm of mental
and brain processes that are now amenable to mechanistic
biological explanations is spreading to encompass some of
the most private and apparently most intangible facets of the
human mind—such as emotions, memory, or morality
(Baertschi 2014; Glannon 2014).
This progress in our knowledge of the brain has been
made possible thanks to the advent of several break-
throughs in technologies and experimental tools that did
not exist 15 or 20 years ago. These include (among others)
neuroimaging methods, transcranial magnetic stimulation,
and deep brain electrodes in humans, but also patch-clamp,
knock-out, viral transfection, or optogenetics in animals.
This is one of several papers published together in Brain Topography
in the ‘‘Special Issue: Clinical and Ethical Implications of
Neuromodulation Techniques’’.
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Furthermore, for the first time in neuroscience history,
some of these techniques might potentially be applied in
similar ways to both humans and animals, thus allowing
much more direct and faster integration of knowledge
gained at different scales of neuronal functions. The con-
vergence between neurobiology, neuroimaging, and neu-
roengineering opens unprecedented perspectives for
translational research.
But even more importantly, these technological advan-
ces open many new perspectives that will now allow
researchers and clinicians not only to measure brain
activity during complex mental states or cognitive tasks,
but also to interfere or modulate neural processes in a way
such as to influence mental experience and behaviors of
patients. Some technologies with this potential for inter-
ventions are already widely available, including invasive
methods such as transcranial or intracranial stimulation
(Schlaepfer and Bewernick 2014; Cabrera et al. 2014), but
also novel use of non-invasive imaging methods (such as
functional magnetic resonance imaging or electroenceph-
alography) for real-time control of brain activity and neu-
rofeedback (Birbaumer et al. 2014; Gevensleben et al.
2014). In addition, progress at the molecular and genetic
levels has induced (and will further promote) the devel-
opment of new drugs that can change brain functions and
possibly alter its synaptic architecture in a long-lasting
(perhaps permanent) manner (Fins and Shapiro 2014).
Fascinating therapeutic applications can now be envisioned
in neurology as well as psychiatry for each of these new
tools, plus their potential combination with each other or
with more traditional approaches (including purely
behavioral training procedures or even psychotherapy). It is
for example becoming plausible to imagine the potential
therapeutic benefits of protocols that would complement
neurological rehabilitation procedures after brain injury
with direct brain stimulation and specific drug regimens in
order to modulate synaptic plasticity, or procedures that
would enhance psychotherapeutic treatment with concom-
itant neurofeedback based on regional brain activity and/or
with drugs modulating genetic expression in select neuro-
nal populations.
Such advances not only offer exciting prospects that
illustrate the immense accomplishment of science, medi-
cine, and technology, but also more generally highlight the
captivating deepening of our knowledge about brain, mind,
and human nature. These advances also raise many new
questions and fears about the safety, limits, and ethical
framework that should define their applications and
development. The possibility to influence brain function in
a powerful manner for psychiatric diseases, for example,
leads to delicate and unprecedented questions about pri-
vacy, individuality, personal identity, or consent (Glannon
2014). In addition, the fact that we have progressively
gained a vast knowledge gained about the mechanisms of
these techniques and the neural substrates of mental pro-
cesses makes their effects on the mind even more salient
and graspable by the general public, which may further
alarm about their potential or perceived danger. Hence,
focal and reversible brain stimulation is still seen as more
invasive than the administration of psychotropic drugs,
which are often well accepted by the public, even though
the latter may produce much more widespread effects on
the both brain and body, and occasionally also affect neural
circuitry in an irreversible manner. In addition, the emer-
gence of new possibilities to influence brain function with
refined technologies is likely to revive some passionate
debates and dark pages of the past history of neuropsy-
chiatry, in relation to lobotomy and electroconvulsive
therapy. The well-known abuse and unfortunate haste in
their applications in the twentieth century has generated not
only caution but also negative biases against similar
interventions, which may ultimately be counterproductive
and detrimental to real therapeutic benefits for some
patients. It is therefore important that emerging new tech-
nologies do not commit a similar fault, but also that they do
not suffer from unjustified generalization of fears.
Indeed, besides the fascination, mystery, and worry of
unwise applications of new intervention techniques to
regulate brain function, there are also great hopes that at
least some of these approaches will improve mental or
neurological diseases and thus alleviate major causes of
human suffering. To guarantee an optimal development of
these techniques by scientists and their acceptance by
patients and their families, it is of paramount importance to
clarify their effects and limitations and to discuss them in
comparison with other current therapeutic means.
These questions were at the heart of a recent symposium
organized at the Brocher Foundation in Geneva, an insti-
tution devoted to promote meetings and reflections around
the ethical and societal implications of modern medicine
(http://www.brocher.ch). During 2 days in June 2012, this
symposium brought together several neuroscientists
working at the frontiers of new technological developments
for therapeutic purposes, as well as philosophers and eth-
icists, who engaged in lively discussions with each other
and with a public audience composed of clinicians, engi-
neers, policy makers, and laymen. This symposium illus-
trated the breadth of current and future technological
opportunities, both for the treatment of neuropsychiatric
diseases and for the enhancement of normal brain func-
tions. Several speakers who participated to the symposium
have subsequently decided to write review or opinion
papers which are now gathered in a special section of this
issue of Brain Topography.
In line with lectures and discussions that took place
during the symposium, the papers gathered in this issue
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critically discuss the benefits and limitations of these
techniques at the present time. However, the global over-
view offered by these authors clearly makes the case that
the future will bring powerful intervention methods that
will not only concern motor control in Parkinson’s disease,
stroke, or tetraplegia (Birbaumer et al. 2014; Cabrera et al.
2014), but also increasingly target higher-level mental
functions such as mood and anxiety regulation (Schlaepfer
and Bewernick 2014), as well as memory, attention,
impulsivity (Gevensleben et al. 2014), or even social
behavior and morality (Baertschi 2014). In virtually each of
these domains, neural intervention techniques are currently
being explored through various approaches including deep
brain stimulation, TMS, neurofeedback, pharmacology,
and even innovative neuroprosthetics devices.
Importantly, in all cases, efficient interventions will
require a precise understanding of brain circuits and
sophisticated means to decode neural activity at both the
local and large-scale levels. Hence, this endeavor will be
intimately connected with the development and validation
of neuroimaging techniques by authors and readers of
Brain Topography. Moreover, there is not only increasing
refinement in brain imaging methods and signal processing
tools in neuroscience, but also growing interest for appli-
cation and cooperation in industry, which will undoubtedly
contribute to rapid expansion of a new field of neurobio-
engineering. Time is therefore ripe for thinking about the
objectives, limitations, risks, and priorities for new neu-
rotechnologies (Fins and Shapiro 2014; Glannon 2014).
Research published in Brain Topography will continue to
steer these developments by providing innovative tools to
assess brain function, but also actively contribute to
establish the best usage of such tools and to educate the
public and policy-makers alike, with the ultimate goal to
help patients and improve society in accordance with rig-
orous ethical guidance.
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